These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1317920)

  • 1. Structure and molecular modeling of GABAA receptor antagonists.
    Rognan D; Boulanger T; Hoffmann R; Vercauteren DP; Andre JM; Durant F; Wermuth CG
    J Med Chem; 1992 May; 35(11):1969-77. PubMed ID: 1317920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Securinine alkaloids: a new class of GABA receptor antagonist.
    Beutler JA; Karbon EW; Brubaker AN; Malik R; Curtis DR; Enna SJ
    Brain Res; 1985 Mar; 330(1):135-40. PubMed ID: 2985189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An approach to the skeleton of the securinega alkaloids. The total synthesis of (+/-)-securinine.
    Liras S; Davoren JE; Bordner J
    Org Lett; 2001 Mar; 3(5):703-6. PubMed ID: 11259041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex interactions between the steroid derivative RU 5135 and the GABAA-receptor complex.
    Cadoni C; Gee KW
    Eur J Pharmacol; 1992 Oct; 227(2):147-51. PubMed ID: 1330646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diazotization and thiocyanate differentiate agonists from antagonists for the high- and low-affinity receptors of gamma-aminobutyric acid.
    Maksay G; Ticku MK
    J Neurochem; 1984 Jul; 43(1):261-8. PubMed ID: 6327917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Securinine, a GABAA receptor antagonist, enhances macrophage clearance of phase II C. burnetii: comparison with TLR agonists.
    Lubick K; Radke M; Jutila M
    J Leukoc Biol; 2007 Nov; 82(5):1062-9. PubMed ID: 17698917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABAA receptor populations bind agonists and antagonists differentially and with opposite affinities.
    Maksay G
    J Neurochem; 1988 Jun; 50(6):1865-71. PubMed ID: 2836561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel GABAA antagonist [3H]SR 95531: microscopic analysis of binding in the rat brain and allosteric modulation by several benzodiazepine and barbiturate receptor ligands.
    McCabe RT; Wamsley JK; Yezuita JP; Olsen RW
    Synapse; 1988; 2(2):163-73. PubMed ID: 2844001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of anisatin with rat brain gamma-aminobutyric acidA receptors: allosteric modulation by competitive antagonists.
    Kakemoto E; Okuyama E; Nagata K; Ozoe Y
    Biochem Pharmacol; 1999 Aug; 58(4):617-21. PubMed ID: 10413298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-aryl-5-(4-piperidyl)-3-isoxazolol GABAA antagonists: synthesis, pharmacology, and structure-activity relationships.
    Frølund B; Jensen LS; Storustovu SI; Stensbøl TB; Ebert B; Kehler J; Krogsgaard-Larsen P; Liljefors T
    J Med Chem; 2007 Apr; 50(8):1988-92. PubMed ID: 17375905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of [3H]diazepam binding in rat cortical membranes by GABAA agonists.
    Wong EH; Iversen LL
    J Neurochem; 1985 Apr; 44(4):1162-7. PubMed ID: 2983028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Central convulsive action of l-securinine].
    Tao SC; Peng JZ; Lu MW
    Zhongguo Yao Li Xue Bao; 1986 Jan; 7(1):9-12. PubMed ID: 2876581
    [No Abstract]   [Full Text] [Related]  

  • 13. Design and synthesis of a new series of 4-alkylated 3-isoxazolol GABA A antagonists.
    Frølund B; Tagmose L; Jørgensen AT; Kristiansen U; Stensbøl TB; Liljefors T; Krogsgaard-Larsen P
    Eur J Med Chem; 2003 Apr; 38(4):447-9. PubMed ID: 12750034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GABA receptors on the cell-body membrane of an identified insect motor neuron.
    Sattelle DB; Pinnock RD; Wafford KA; David JA
    Proc R Soc Lond B Biol Sci; 1988 Jan; 232(1269):443-56. PubMed ID: 2451252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new general access to either type of Securinega alkaloids: synthesis of securinine and (-)-allonorsecurinine.
    Alibés R; Ballbé M; Busqué F; de March P; Elias L; Figueredo M; Font J
    Org Lett; 2004 May; 6(11):1813-6. PubMed ID: 15151421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of securinine on 5 kinds of neurotransmitter receptors and membrane potential of the frog spinal cord].
    Qu ZW; Zhang JT
    Yao Xue Xue Bao; 1987 Apr; 22(4):305-7. PubMed ID: 2825466
    [No Abstract]   [Full Text] [Related]  

  • 17. Structural factors governing agonist and antagonist activity in the GABAA system.
    Pooler GW; Steward EG
    Biochem Pharmacol; 1988 Mar; 37(5):943-5. PubMed ID: 2830887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total syntheses of (±)-securinine and (±)- allosecurinine.
    Chen JH; Levine SR; Buergler JF; McMahon TC; Medeiros MR; Wood JL
    Org Lett; 2012 Sep; 14(17):4531-3. PubMed ID: 22913575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suramin is a novel competitive antagonist selective to α1β2γ2 GABA
    Luo H; Wood K; Shi FD; Gao F; Chang Y
    Neuropharmacology; 2018 Oct; 141():148-157. PubMed ID: 30172846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chiroptical study and absolute configuration of securinine oxidation products.
    Chirkin E; Atkatlian W; Do Q; Gaslonde T; Dufat TH; Michel S; Lemoine P; Genta-Jouve G; Porée FH
    Nat Prod Res; 2015; 29(13):1235-42. PubMed ID: 25790256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.